|
Pfizer to Make $54 Billion Off Treating COVID Over and Over
Pfizer expects record profits in 2022 due to its COVID-19 shots and antiviral medication. Its treatment failures, necessitating boosters and multiple courses of treatment, allows it to double-dip, profiting off both a failed preventative – the shot – and subsequent treatment for the COVID-19 infection it was supposed to prevent.
|
|
|
|
|
This Novel Vitamin Therapy Could Slash Sepsis Death Rate
Each year, an estimated 1 million people get sepsis or blood poisoning, and up to half die. For the priciest condition treated in hospitals, this novel therapy could change all that while reducing mortality from 40% to only 8.5%.
|
|
|
|
|